Jushi Holdings (JUSHF) Operating Income (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Operating Income of $714000.0 for Q2 2026, down 80.18% year-over-year from $3.6 million in Q2 2025, and down 54.9% quarter-over-quarter from $1.6 million in Q1 2026.
Jushi Holdings (JUSHF) Operating Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Operating Income for 6 consecutive years, with $714000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Income fell 80.18% year-over-year to $714000.0; the TTM figure through Jun 2026 stood at $5.4 million (up 7529.58% YoY), while the FY2025 annual figure was $4.9 million, down 55.34% from the prior year.
- Operating Income slipped to $714000.0 in Q2 2026 per JUSHF's latest filing, from $1.6 million in the prior quarter.
- Across five years, Operating Income topped out at $8.4 million in Q2 2024 and bottomed at -$139.2 million in Q4 2022.
- Historically, Operating Income has averaged -$11.4 million across 5 years, with a median of $447000.0 in 2024.
- Annual changes were most pronounced in 2022 — Operating Income tumbled 2667.31% — and 2025, when it soared 1198.89%.
- Jushi Holdings' Operating Income stood at -$139.2 million in 2022, then surged by 95.31% to -$6.5 million in 2023, then jumped by 71.84% to -$1.8 million in 2024, then jumped by 142.5% to $782000.0 in 2025, then fell by 8.7% to $714000.0 in 2026.
- Business Quant data shows JUSHF's Operating Income at $714000.0 in Q2 2026, $1.6 million in Q1 2026, and $782000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 714,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 714,000.00 |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 782,000.00 |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 8.40 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | -2.51 Mn |
| Dec 31, 2022 | -139.21 Mn |
| Sep 30, 2022 | -50.45 Mn |
| Jun 30, 2022 | -12.08 Mn |
| Mar 31, 2022 | -18.20 Mn |
| Dec 31, 2021 | -26.03 Mn |
| Sep 30, 2021 | -1.82 Mn |